Related Experiment Video
Updated: Mar 12, 2026

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication
Shahzada Khan1, Erik M Woodruff1, Martin Trapecar1
1Virology and Immunology, Gladstone Institutes, San Francisco, CA 94158.
Abstract:
Understanding the host immune response to vaginal exposure to RNA viruses is required to combat sexual transmission of this class of pathogens. In this study, using lymphocytic choriomeningitis virus (LCMV) and Zika virus (ZIKV) in wild-type mice, we show that these viruses replicate in the vaginal mucosa with minimal induction of antiviral interferon and inflammatory response, causing dampened innate-mediated control of viral replication and a failure to mature local antigen-presenting cells (APCs). Enhancement of innate-mediated inflammation in the vaginal mucosa rescues this phenotype and completely inhibits ZIKV replication. To gain a better understanding of how this dampened innate immune activation in the lower female reproductive tract may also affect adaptive immunity, we modeled CD8 T cell responses using vaginal LCMV infection. We show that the lack of APC maturation in the vaginal mucosa leads to a delay in CD8 T cell activation in the draining lymph node and hinders the timely appearance of effector CD8 T cells in vaginal mucosa, thus further delaying viral control in this tissue. Our study demonstrates that vaginal tissue is exceptionally vulnerable to infection by RNA viruses and provides a conceptual framework for the male to female sexual transmission observed during ZIKV infection.
Insights
Vaginal exposure to RNA viruses like Zika virus causes minimal immune response, hindering viral control. Enhancing inflammation in vaginal tissue effectively inhibits viral replication and improves immune responses.
Area of Science:
- Immunology
- Virology
- Reproductive Health
Background:
- Sexual transmission of RNA viruses poses a significant public health challenge.
- Understanding the female reproductive tract's immune response to viral pathogens is crucial for developing effective interventions.
Purpose of the Study:
- To investigate the host immune response to vaginal RNA virus exposure.
- To elucidate the mechanisms underlying viral replication and immune evasion in the vaginal mucosa.
- To explore strategies for enhancing immune control of vaginal viral infections.
Main Methods:
- Utilized mouse models with lymphocytic choriomeningitis virus (LCMV) and Zika virus (ZIKV) infections.
- Assessed viral replication, interferon and inflammatory responses in the vaginal mucosa.
- Evaluated antigen-presenting cell (APC) maturation and CD8 T cell responses.
- Investigated the impact of enhanced innate inflammation on viral control.
Main Results:
- RNA viruses replicate in the vaginal mucosa with minimal antiviral and inflammatory responses.
- Dampened innate immunity and impaired APC maturation hinder viral control.
- Enhancing vaginal mucosal inflammation inhibits ZIKV replication and rescues the immune phenotype.
- Delayed CD8 T cell activation and impaired effector function contribute to prolonged viral presence.
Conclusions:
- Vaginal tissue is highly susceptible to RNA virus infection due to a weak innate immune response.
- Augmenting innate inflammation in the vaginal mucosa is a promising strategy to control viral replication.
- The findings provide a framework for understanding male-to-female sexual transmission of viruses like ZIKV.
Related Concept Videos
Viruses with RNA Genomes
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viral Mutations
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Retrovirus Life Cycles
Retroviruses

